Diabeloop
PrivateLast Round
Series C
Extension
Mar 26, 2024
Total Funding Raised
$126.33M
Momentum Score
50 /100
Company Overview
Diabeloop is a medical technology company that develops artificial intelligence-based solutions to automate and personalize the treatment of diabetes. Its primary products are hybrid closed-loop systems that connect a continuous glucose monitor (CGM) and an insulin pump with a self-learning algorithm to analyze data in real-time and automatically deliver the appropriate dose of insulin. The company's mission is to alleviate the constant mental burden for people living with diabetes and improve their quality of life. Founded in 2015, Diabeloop has commercially launched its solutions in several European countries and is pursuing expansion into the U.S. and Asian markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Precision Medicine
Business Model
B2B2C
Customer Profile
Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diabeloop Comps
Public and private peers based on sector, stage, and business model.
Diabeloop Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Mar 26, 2024 | ||||
| Debt | Jun 2, 2022 | ||||
| Series C | Jun 2, 2022 | ||||
| Series B | Dec 2, 2019 | ||||
| Grant | Nov 1, 2018 |
Key People
Founding team and executive leadership
Diabeloop Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Odyssée Venture | Series B, Series C |
| Bpifrance | Debt |
| Kreaxi | Series B, Series C |
| Sofimac Innovation | Series B |
| Innovacom | Series C |
| Supernova Invest | Series B, Series C |
| Cemag Invest | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Equipped over 10,000 people since 2021 launch.
- Mar 9, 2026
Attending the Advanced Technologies & Treatments for Diabetes (ATTD) 2026 conference.
Diabeloop Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Diabeloop's valuation, stock price, and market status.
